Tissue factor-positive monocytes in children with sickle cell disease: Correlation with biomarkers of haemolysis

British Journal of Haematology

Volumn 157, Issue 3, 2012, Pages 370-380

  Setty, B N Yamaja ^a   Key, Nigel S ^b   Rao, A Koneti ^c   Gayen Betal, Suhita ^a   Krishnan, Suba ^a   Dampier, Carlton D ^d   Stuart, Marie J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers of haemolysis; Biomarkers of inflammation; Coagulation abnormalities; Sickle cell disease; Tissue factor positive monocytes

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; D DIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEMOGLOBIN S; LACTATE DEHYDROGENASE; MICROPARTICLE ASSOCIATED TISSUE FACTOR; PADGEM PROTEIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; WHOLE BLOOD TISSUE FACTOR;

ARTICLE; BLOOD CLOTTING DISORDER; CELL ACTIVATION; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HEMOLYSIS; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; MULTIPLE REGRESSION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETICULOCYTE; SCHOOL CHILD; SICKLE CELL ANEMIA; UNIVARIATE ANALYSIS;

ANEMIA, SICKLE CELL; ANTITHROMBIN III; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FLOW CYTOMETRY; HEMOLYSIS; HUMANS; INFLAMMATION MEDIATORS; MONOCYTES; PEPTIDE HYDROLASES; THROMBOPLASTIN;

EID: 84859512051     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09065.x     Document Type: Article

References (43)

1. Adedeji, M.O., Cespedes, J., Allen, K., Subramony, C. & Hughson, M.D. (2001) Pulmonary thrombotic arteriopathy in patients with sickle cell disease. Archives of Pathology and Laboratory Medicine, 125, 1436-1441.
2. Ataga, K.I., Cappellini, M.D. & Rachmilewitz, E.A. (2007) β-Thalassaemia and sickle cell anaemia as paradigms of hypercoagulabilty. British Journal of Haematology, 139, 3-13.
3. Ataga, K.I., Brittain, J.E., Desai, P., May, R., Jones, S., Delaney, J., Strayhorn, D., Hinderliter, A. & Key, N.S. (2012) Association of coagulation activation with clinical complications in sickle cell disease. PLoS ONE, 7, e29786.
4. van Beers, E.J., Marianne, C.L., Schaap, R.J., Berckmans, R.J., Nieuwland, R., Sturk, A., van Doormaal, F.F., Meijers, J.C.M., Biemond, B.J. & on behalf of the CURAMA study group. (2009) Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica, 94, 1513-1519.
5. Belcher, J.D., Marker, P.H., Weber, J.P., Hebbel, R.P. & Vercellotti, G.M. (2000) Activated monocyes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlution. Blood, 96, 2451-2459.
6. Blann, A.D., Mohan, J.S., Bareford, D. & Lip, G.Y. (2008) Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype. Journal of Thrombosis and Thrombolysis, 25, 185-189.
7. Brambilla, M., Camera, M., Colnago, D., Marenzi, G., De Metrio, M., Giesen, P.L., Balduini, A., Veglia, F., Gertow, K., Biglioli, P. & Tremoli, E. (2008) Tissue factor in patients with acute coronary syndromes. Expression in platelets, leukocytes, and platelet-leukocyte aggregates. Arteriosclerosis Thrombosis and Vascular Biology, 28, 947-953.
8. Camerer, E., Kolstø, A.-B. & Prydz, H. (1996) Cell biology of tissue factor, the principal initiator of blood coagulation. Thrombosis Research, 81, 1-41.
9. Colella, M.P., Machado-Neto, J., Quaino, S.K.P., Conran, N., Annichino-Bizzacchi, J.M., Costa, F.F., Saad, S.O., de Paula, E.V. & Traina, F. (2011) Hydroxyurea reduces the hypercoagulable state in Sickle cell anemia. Blood, 118, abstract 1068.
10. Dessap, A.M., Deux, J.-F., Abidi, N., Lavenu-Bombled, C., Melica, G., Renaud, B., Godeau, B., Adnot, S., Brochard, L., Brun-Buisson, C., Galacteros, F., Rahmouni, A., Habibi, A. & Maitre, B. (2011) Pulmonary arterythrombosis during acute chest syndrome in sickle cell disease. American Journal of Respiratory and Critical Care Medicine, 184, 1022-1029.
11. Hebbel, R.P. (2011) Reconstructing sickle cell disease: a data-based anslysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine. American Journal of Hematology, 86, 123-154.
12. Hillery, C.A. & Panepinto, J.A. (2004) Pathophysiology of stroke in sickle cell disease. Microcirculation, 11, 195-208.
13. Johnson, G.J., Leis, L.A. & Bach, R.R. (2009) Tissue factor activity of blood mononuclear cells is increased after total knee arthroplasty. Thrombosis and Haemostasis, 102, 728-734.
14. de Jong, K., Emerson, R.K., Butler, J., Bastacky, J., Mohandas, N. & Kuypers, F.A. (2001) Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia. Blood, 98, 1577-1584.
15. Kato, G.J., Hebbel, R.P., Steinberg, M.H. & Gladwin, M.T. (2009) Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions. American Journal of Hematology, 84, 618-625.
16. Kaul, D.K. & Hebbel, R.P. (2000) Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. Journal of Clinical Investigation, 106, 411-420.
17. Key, N.S. & Mackman, N. (2010) Tissue factor and its measurement in whole blood, plasma, and microparticles. Seminars in Thrombosis and Hemostasis, 36, 865-875.
18. Key, N.S., Slungaard, A., Dandelet, L., Nelson, S.C., Moertel, C., Styles, L.A., Kuypers, F.A. & Bach, R.R. (1998) Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood, 91, 4216-4223.
19. Khorana, A.A., Francis, C.W., Menzies, K.E., Wang, J.G., Hyrien, O., Hathcock, J., Mackman, N. & Taubman, M.B. (2008) Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. Journal of Thrombosis and Haemostasis, 6, 1983-1985.
20. Krishnan, S., Setty, Y., Gayen-Betal, S., Vijender, V., Rao, K., Dampier, C. & Stuart, M. (2010) Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises. British Journal of Haematology, 148, 797-804.
21. Lee, S.P., Ataga, K.I., Orringer, E.P., Phillips, D.R. & Parise, L.V. (2006) Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation. Arteriosclerosis Thrombosis and Vascular Biology, 26, 1626-1631.
22. Lee, R.D., Barcel, D.A., Williams, J.C., Wang, J.G., Boles, J.C., Manly, D.A., Key, N.S. & Mackman, N. (2012) Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. Thrombosis Research, 129, 80-85.
23. Mackman, N. (2004) Role of tissue factor in hemostasis, thrombosis and vascular development. Arteriosclerosis Thrombosis and Vascular Biology, 24, 1015-1022.
24. Manly, D.A., Wang, J., Glover, S.L., Kasthuri, R., Leibman, H.A., Key, N.S. & Mackman, N. (2009) Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thrombosis Research, 125, 511-512.
25. Mohan, J.S., Lip, G.Y., Wright, J., Bareford, D. & Blann, A.D. (2005) Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation. Blood Coagulation and Fibrinolysis, 16, 209-214.
26. Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Pegelow, C.H., Gill, F.M. & the cooperative study of sickle cell disease. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288-294.
27. Parhami-Seren, B., Butenas, S., Krudysz-Amblo, J. & Mann, K.G. (2006) Immunologic quantification of tissue factors. Journal of thrombosis and Haemostasis, 4, 1745-1755.
28. Setty, B.N.Y., Rao, A.K. & Stuart, M.J. (2001) Thrombophilia in sickle cell disease: the red cell connection. Blood, 98, 3228-3233.
29. Setty, B.N.Y., Stuart, M.J., Dampier, C., Brodecki, D. & Allen, J.L. (2003) Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet, 362, 1450-1455.
30. Setty, B.N.Y., Betal, S.G., Zhang, J. & Stuart, M.J. (2008) Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia. Journal of Thrombosis and Haemostasis, 6, 2202-2209.
31. Shet, A.S., Aras, O., Gupta, K., Hass, M.J., Rausch, D.J., Saba, N., Koopmeiners, L., Key, N.S. & Hebbel, R.P. (2003) Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood, 102, 2678-2683.
32. Solovey, A., Gui, L., Key, N.S. & Hebbel, R.P. (1998) Tissue factor expression by endothelial cells in sickle cell anemia. Journal of Clinical Investigation, 101, 1899-1904.
33. Solovey, A., Kollander, R., Shet, A., Milbauer, L.C., Choong, S., Panoskaltsis-Mortari, A., Blazar, B.R., Kelm, Jr, R.J. & Hebbel, R.P. (2004) Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. Blood, 104, 840-846.
34. Stein, P.A., Beemath, A., Meyers, F.A., Skaf, E. & Olson, R.E. (2006) Deep venous thrombosis and pulmonary embolism in hospitalized patients with SCD. American Journal of Medicine, 119, 897.e7-897. e11.
35. Stuart, M.J. & Setty, B.N.Y. (1999) Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood, 94, 1555-1560.
36. Stuart, M.J. & Setty, B.N.Y. (2001) Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology. Pediatric Pathology and Molecular Medicine, 20, 27-46.
37. Tomer, A., Harker, L.A., Kasey, S. & Eckman, J.R. (2001) Thrombogenesis in sickle cell disease. Journal of Laboratory and Clinical Medicine, 137, 398-407.
38. Turhan, A., Weiss, L.A., Mohandas, N., Coller, B.S. & Frenette, P.S. (2002) Primary role for adherent leukocytes in sickle cell vascular occlution: a new paradigm. Proceedings of the National Academy of Sciences of the United States of America, 99, 3047-3051.
39. Vasse, M., Lahary, A., Chevallier, C., Blois, S., Levesque, H., Vannier, J.P. & Lenormand, B. (2003) Hypercoagulability in sickle cell disease: increased monocyte tissue factor expression and increased erythrocyte microparticles expressing phosphatidylserine. Journal of Thrombosis and Haemostasis, 1(Suppl. 1), abstract P0927.
40. Wang, W.C., Ware, R.E., Miller, S.T., Iyer, R.V., Casella, J.F., Minniti, C.P., Rana, S., Thornburg, C.D., Rogers, Z.R., Kalpatthi, R.V., Barredo, J.C., Brown, R.C., Sarnaik, S.A., Howard, T.H., Wynn, L.W., Kutlar, A., Armstrong, F.D., Files, B.A., Goldsmith, J.C., Waclawiw, M.A., Huang, X., Thompson, B.W. & BABY HUG investigators (2011) Hydroxycarbamide in very young children with sickle-cell anaemia multicentre, randomized, controlled trail (BABY HUG). Lancet, 377, 1663-1672.
41. Ware, R.E. (2010) How I use hydroxyurea to treat young patients with sickle cell anemia. Blood, 115, 5300-5311.
42. Westerman, M.P., Green, D., Gilman-Sachs, A., Beaman, K., Freels, S., Boggio, L., Allen, S., Zuckerman, L., Schlegel, R. & Williamson, P. (1999) Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. Journal of Laboratory and Clinical Medicine, 134, 352-362.
43. Yasin, Z., Witting, S., Palascak, M.B., Joiner, C.H., Rucknagel, D.L. & Franco, R.S. (2003) Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density and hemoglobin F. Blood, 102, 365-370.